The article highlights Aramark's strong FY25 outlook, supported by organic growth and a solid balance sheet. The 4Q24 earnings were in line with expectations, indicating stability. The launch of Avendra is a strategic move to enhance margins, which is likely to positively impact the stock price in the short term.